MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-11-2026
Stryker Corporation Operating Expenses 2011-2026 | SYK
Annual Operating Expenses Stryker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.2 B | 10.8 B | 9.17 B | 8.74 B | 8.38 B | 6.83 B | 6.79 B | 6.38 B | 5.71 B | 5.17 B | 4.44 B | 4.38 B | 4.74 B | 4.06 B | 3.73 B | 3.28 B | 2.94 B | 3.07 B | 2.83 B | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.2 B | 2.83 B | 5.93 B |
Quarterly Operating Expenses Stryker Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.87 B | 2.72 B | 2.73 B | 2.91 B | 2.43 B | 2.36 B | 2.36 B | 2.23 B | 2.22 B | 2.28 B | - | 1.97 B | 2.05 B | 2.29 B | - | 2.07 B | 2.04 B | 2.05 B | - | 1.6 B | 1.57 B | 1.7 B | - | 1.7 B | 1.77 B | 1.76 B | - | 1.58 B | 1.52 B | 1.55 B | - | 1.46 B | 1.49 B | 1.41 B | - | 1.39 B | 1.34 B | 1.18 B | - | 1.25 B | 1.18 B | 1.15 B | - | 1.11 B | 1.35 B | 1.4 B | - | 1.32 B | 1.19 B | 1.09 B | - | 947 M | 989 M | 976 M | - | 918 M | 932 M | 903 M | 756 M | 771 M | 771 M | 803 M | 708 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.91 B | 708 M | 1.59 B |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
301 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.72 | 2.45 % | $ 332 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 8.02 | -3.02 % | $ 1.2 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
47.1 M | $ 4.35 | 1.16 % | $ 163 M |  France |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
249 M | $ 2.3 | 0.22 % | $ 50.7 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.04 | 2.96 % | $ 17.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.47 | 1.78 % | $ 29.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 17.98 | -2.12 % | $ 422 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.8 | -2.04 % | $ 387 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.96 | -2.13 % | $ 71.3 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 75.51 | 2.28 % | $ 4.12 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.55 | -0.32 % | $ 63.1 M | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 3.68 | 1.52 % | $ 544 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 38.07 | -0.39 % | $ 322 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 1.02 | -1.44 % | $ 42.7 M | USA |
 |
Butterfly Network
BFLY
|
132 M | $ 4.56 | 1.9 % | $ 1.13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Orthofix Medical
OFIX
|
344 M | $ 9.68 | -9.95 % | $ 383 M |  Curacao |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
887 M | $ 85.23 | 0.5 % | $ 11.5 B | USA |
 |
Profound Medical Corp.
PROF
|
52.6 M | $ 6.89 | 0.88 % | $ 208 M | Canada |
 |
Insulet Corporation
PODD
|
531 M | $ 153.27 | -1.03 % | $ 10.8 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.17 | -2.85 % | $ 1.12 B | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.43 | 1.67 % | $ 6.74 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 42.2 | -3.74 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 90.97 | 1.89 % | $ 3.16 B | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 87.78 | 2.33 % | $ 51.3 B | USA |
 |
TransMedics Group
TMDX
|
254 M | $ 70.27 | 1.94 % | $ 2.39 B | USA |